Eledon Pharmaceuticals (ELDN) Other Non-Current Assets (2013 - 2026)

Eledon Pharmaceuticals' Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $32.4 million for Q1 2026.

• Quarterly Other Non-Current Assets rose 9048.59% year-over-year to $32.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.4 million (up 9048.59% YoY) and the FY2025 annual result came in at $322000.0, down 11.29% from the prior year.
• Other Non-Current Assets was $32.4 million for Q1 2026 at Eledon Pharmaceuticals, up from $322000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $32.4 million in Q1 2022 and bottomed at $186000.0 in Q4 2023.
• A 5-year average of $15.4 million and a median of $369000.0 in 2023 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets sank 99.43% — and 2025, when it surged 15321.9%.
• Eledon Pharmaceuticals' Other Non-Current Assets stood at $32.4 million in 2022, then sank by 99.43% to $186000.0 in 2023, then soared by 95.16% to $363000.0 in 2024, then declined by 11.29% to $322000.0 in 2025, then jumped by 9957.76% to $32.4 million in 2026.
• Business Quant data shows ELDN's Other Non-Current Assets at $32.4 million in Q1 2026, $322000.0 in Q4 2025, and $32.4 million in Q3 2025.